Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather Thorne

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Nature Communications|January 10, 2017
Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectoriesRenea A Taylor, Michael Fraser, Julie Livingstone, et al.
JCO Precision Oncology|February 17, 2022
Circulating Tumor DNA Analysis and Functional Imaging Provide Complementary Approaches for Comprehensive Disease Monitoring in Metastatic MelanomaStephen Q Wong, Jeanette M Raleigh, Jason Callahan, et al.
European Journal of Cancer (Oxford, England : 1990)|March 27, 2023
Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriersRebeca Lozano, Elena Castro, Fernando Lopez-Campos, et al.
Nature|October 20, 2025
Parity and lactation induce T-cell-mediated breast cancer protectionBalaji Virassamy, Franco Caramia, Peter Savas, et al.
Nature Genetics|February 28, 2023
Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancerNikki L Burdett, Madelynne O Willis, Kathryn Alsop, et al.
Histopathology|March 31, 2023
BRCA1 and BRCA2 carriers with breast, ovarian and prostate cancer demonstrate a different pattern of metastatic disease compared with non-carriers: results from a rapid autopsy programmeHeather Thorne, Lisa Devereux, Jason Li, et al.
Nature Communications|March 5, 2021
Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doublingIsmael A Vergara, Christopher P Mintoff, Shahneen Sandhu, et al.
Nature Communications|August 20, 2021
The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncologyGail P Risbridger, Ashlee K Clark, Laura H Porter, et al.
The Journal of Pathology|March 29, 2024
Research autopsy programmes in oncology: shared experience from 14 centres across the worldTatjana Geukens, Marion Maetens, Jody E Hooper, et al.
European Urology|July 28, 2018
Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed TherapyMitchell G Lawrence, Daisuke Obinata, Shahneen Sandhu, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Nature Communications|January 10, 2017
Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectoriesRenea A Taylor, Michael Fraser, Julie Livingstone, et al.
JCO Precision Oncology|February 17, 2022
Circulating Tumor DNA Analysis and Functional Imaging Provide Complementary Approaches for Comprehensive Disease Monitoring in Metastatic MelanomaStephen Q Wong, Jeanette M Raleigh, Jason Callahan, et al.
European Journal of Cancer (Oxford, England : 1990)|March 27, 2023
Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriersRebeca Lozano, Elena Castro, Fernando Lopez-Campos, et al.
Nature|October 20, 2025
Parity and lactation induce T-cell-mediated breast cancer protectionBalaji Virassamy, Franco Caramia, Peter Savas, et al.
Nature Genetics|February 28, 2023
Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancerNikki L Burdett, Madelynne O Willis, Kathryn Alsop, et al.
Histopathology|March 31, 2023
BRCA1 and BRCA2 carriers with breast, ovarian and prostate cancer demonstrate a different pattern of metastatic disease compared with non-carriers: results from a rapid autopsy programmeHeather Thorne, Lisa Devereux, Jason Li, et al.
Nature Communications|March 5, 2021
Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doublingIsmael A Vergara, Christopher P Mintoff, Shahneen Sandhu, et al.
Nature Communications|August 20, 2021
The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncologyGail P Risbridger, Ashlee K Clark, Laura H Porter, et al.
The Journal of Pathology|March 29, 2024
Research autopsy programmes in oncology: shared experience from 14 centres across the worldTatjana Geukens, Marion Maetens, Jody E Hooper, et al.
European Urology|July 28, 2018
Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed TherapyMitchell G Lawrence, Daisuke Obinata, Shahneen Sandhu, et al.
Pageof 5